Lewis Nicky, Eggleston Barry, Chandler Redonna K, Goddard-Eckrich Dawn, Luster Jamie E, Beard Dacia D, Rodgers Emma, Chahine Rouba, Westgate Philip M, Benjamin Shoshana N, Holloway JaNae, Clarke Thomas, Lefebvre R Craig, Stein Michael D, Helme Donald W, Reynolds Jennifer, Walsh Sharon L, Freedman Darcy, El-Bassel Nabila, Stephens Kara, Silwal Anita, Lofwall Michelle, Childerhose Janet E, Surratt Hilary L, Crockett Brooke N, Farmer Amy L, David James L, Fanucchi Laura, Harness Judy, Wilburn Ben, Bursey Kelli, Mattson Kristin, Mann Sarah, Jackson Rebecca D, Shadwick Aimee, Calver Katherine, Chassler Deborah, Kimball Jennifer, Regan Nancy, Samet Jeffrey H, Sword-Cruz Rachel, Slater Michael D
University of Kentucky, Lexington, Kentucky, United States of America.
RTI International, Research Triangle Park, North Carolina, United States of America.
PLoS One. 2024 Dec 4;19(12):e0308965. doi: 10.1371/journal.pone.0308965. eCollection 2024.
The HEALing Communities Study (HCS) included health campaigns as part of a community-engaged intervention to reduce opioid-related overdose deaths in 67 highly impacted communities across Kentucky, Massachusetts, New York, and Ohio. Five campaigns were developed with community input to provide information on opioid use disorder (OUD) and overdose prevention, reduce stigma, and build demand for evidence-based practices (EBPs). An evaluation examined the recognition of campaign messages about naloxone and whether stigma and efficacy beliefs regarding OUD treatment and naloxone changed in HCS intervention communities.
Data were collected through surveys offered on Facebook/Instagram to members of communities participating in the HCS intervention and wait-list control communities.
Participants in HCS intervention communities reported a reduction in stigma regarding OUD and increased efficacy beliefs regarding naloxone associated with recognition of campaign messages. However, this finding is cautiously interpreted as there was no clear evidence for recognition differences between the treatment/control conditions.
Study findings indicate associations between campaign message recognition and positive outcomes. Results also highlight possible challenges concerning evaluations of social media campaigns using conventional evaluation techniques.
ClinicalTrials.gov NCT04111939.
“治愈社区研究”（HCS）将健康宣传活动作为社区参与干预措施的一部分，以减少肯塔基州、马萨诸塞州、纽约州和俄亥俄州67个受影响严重社区中与阿片类药物相关的过量用药死亡。在社区参与下开展了五项宣传活动，以提供有关阿片类药物使用障碍（OUD）和过量用药预防的信息，减少污名化，并增强对循证实践（EBP）的需求。一项评估调查了对纳洛酮宣传信息的认知情况，以及在HCS干预社区中对OUD治疗和纳洛酮的污名化观念及疗效信念是否发生了变化。
通过在脸书/照片墙向参与HCS干预的社区成员以及候补对照社区成员进行的调查收集数据。
HCS干预社区的参与者报告称，与对宣传信息的认知相关，对OUD的污名化有所减少，对纳洛酮的疗效信念有所增强。然而，由于没有明确证据表明治疗/对照条件之间存在认知差异，这一发现需谨慎解读。
研究结果表明宣传信息认知与积极结果之间存在关联。结果还凸显了使用传统评估技术对社交媒体宣传活动进行评估时可能面临的挑战。
ClinicalTrials.gov NCT04111939。
